The regulatory environment Determining the appropriate balance between drug safety and efficacy in patients with malignant disease is one of the most challenging judgments that regulators have to ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

Recently approved xanomeline and trospium chloride (Cobenfy) demonstrated long-term efficacy and safety in patients with ...

The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.

The aim of this review is to summarize the data on the efficacy and safety of inhaled anticholinergic drugs in asthma, and to propose a possible use of these drugs in asthma management.

There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

The No Pain Act will mandate Medicare insurance coverage for non-opioid pain management, including evidence-based treatments, ...

Targeting the kappa opioid receptor with an agonist is a new pharmacy strategy for treating moderate to severe CKD-associated ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

There is currently no cure for IBD. Medications, surgery, and lifestyle changes can help alleviate symptoms Recently, the ...